Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-26-058766
Filing Date
2026-05-11
Accepted
2026-05-11 17:27:28
Documents
7
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2614096d1_6k.htm 6-K 11082
2 EXHIBIT 99.1 tm2614096d1_ex99-1.htm EX-99.1 296396
3 EXHIBIT 99.2 tm2614096d1_ex99-2.htm EX-99.2 248301
4 EXHIBIT 99.3 tm2614096d1_ex99-3.htm EX-99.3 10693
5 EXHIBIT 99.4 tm2614096d1_ex99-4.htm EX-99.4 10746
6 GRAPHIC tm2614096d1_ex99-1img001.jpg GRAPHIC 7852
7 GRAPHIC tm2614096d1_ex99-2img001.jpg GRAPHIC 11645
  Complete submission text file 0001104659-26-058766.txt   605465
Mailing Address 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5
Business Address 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5 289-910-0850
Cardiol Therapeutics Inc. (Filer) CIK: 0001702123 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40712 | Film No.: 26964611
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)